Author | Heil, G | dc.contributor.author |
Author | Bunjes, D | dc.contributor.author |
Author | Arnold, R | dc.contributor.author |
Author | Goebel, M | dc.contributor.author |
Author | Heimpel, Hermann | dc.contributor.author |
Author | Kurrle, E | dc.contributor.author |
Date of accession | 2018-06-27T08:52:19Z | dc.date.accessioned |
Available in OPARU since | 2018-06-27T08:52:19Z | dc.date.available |
Date of first publication | 1992 | dc.date.issued |
Language | en | dc.language.iso |
Publisher | Universität Ulm | dc.publisher |
Keyword | ACUTE MYELOID LEUKEMIA | dc.subject |
Keyword | RELAPSE | dc.subject |
Keyword | IDARUBICIN | dc.subject |
Keyword | REINDUCTION | dc.subject |
Keyword | TOXICITY | dc.subject |
Keyword | acute myelogenous leukemia | dc.subject |
Keyword | bone-marrow transplantation | dc.subject |
Keyword | 4-demethoxydaunorubicin idarubicin | dc.subject |
Keyword | adult patients | dc.subject |
Keyword | therapy | dc.subject |
Keyword | chemotherapy | dc.subject |
Keyword | daunorubicin | dc.subject |
Keyword | induction | dc.subject |
Dewey Decimal Group | DDC 610 / Medicine & health | dc.subject.ddc |
Title | IDARUBICIN, CYTOSINE-ARABINOSIDE AND ETOPOSIDE FOR RELAPSED OR REFRACTORY ACUTE MYELOID-LEUKEMIA | dc.title |
Resource type | Wissenschaftlicher Artikel | dc.type |
Institution | UKU. Klinik für Innere Medizin III | uulm.affiliationSpecific |
DCMI Type | Text | uulm.typeDCMI |
Category | Publikationsnachweise | uulm.category |
Source - Title of source | Onkologie | source.title |
Source - Place of publication | Karger Publishers | source.publisher |
Source - Volume | 15 | source.volume |
Source - Issue | 1 | source.issue |
Source - Year | 1992 | source.year |
Source - From page | 12 | source.fromPage |
Source - To page | 19 | source.toPage |
Source - ISSN | 0378-584X | source.identifier.issn |
Open Access | No | uulm.OA |
Community | Universitätsklinikum Ulm | uulm.community |
WoS | A1992HN14500002 | uulm.identifier.wos |
Bibliography | uulm | uulm.bibliographie |